ALT Alterations in RNA processing have recently emerged as a new cancer hallmark and a promising target for cancer therapies. This inaugural Science Research Conference (SRC) explores how RNA processing contributes to cancer and how this process can be targeted for the development of novel cancer therapeutics. The conference will bring together cancer researchers, RNA scientists, clinicians, and drug development companies. The program’s main goals are to accelerate the translation of fundamental advances into novel clinical cancer therapeutics, and to encourage and support junior investigators/trainees, women, and minority scientists to continue pursuing research at the intersection of RNA and cancer.